Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Find out when rewards points are truly worth it. Maximize your benefits and learn how to save more on your travels.
15,541 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
When a senior executive sells thousands of shares, investors often jump to conclusions. This article breaks down what...
In 2025, roughly one-third of Gen Z and young millennials lived with their parents, a record not seen since the early...
Federal prosecutors dismantle a sprawling fraud machine that used mass texting, scripted pitches, and fake crypto pla...
Bank of America’s macro team expects the Fed to deliver three 25-basis-point hikes this year, pushing rates higher an...
Venture capital veteran Alfred Lin of Sequoia counters doom-laden SaaS forecasts, arguing AI-driven productivity and ...
When a lockup period ends, insiders can sell their shares, creating potential price swings. This article breaks down ...
Gates Capital Management just raised its TIC Solutions position even as TIC’s stock fell this year. Learn what this m...
Rivian has made bold moves in a high-stakes market. With shares drifting down this year, this guide weighs the case f...
O-I Glass has climbed about 17% over the past year, even as a large fund unloaded roughly $80 million worth of stock....
A leading market strategist argues the AI-led pullback is routine profit-taking after a rapid rally, with the AI infr...
If you’re considering Walmart stock, you should understand three core ideas that drive the business and the stock's p...